AbbVie Inc.
DE ˙ XTRA ˙ US00287Y1091
185,70 € ↓ -2,40 (-1,28%)
2026-06-02
AKTIENPREIS
SecurityDE:4AB / AbbVie Inc.
InstitutionNorthern Trust Corp
Latest Disclosed Ownership21,211,382 shares
Latest Disclosed Value $ 4,613,263,471
Northern Trust Corp reports 2.40% decrease in ownership of 4AB / AbbVie Inc.

On May 14, 2026 - Northern Trust Corp filed a 13F-HR form disclosing ownership of 21,211,382 shares of AbbVie Inc. (DE:4AB) valued at $3,932,590,223 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 21,733,923 shares of AbbVie Inc.. This represents a change in shares of -2.40% during the quarter. The current value of the position is $3,938,953,637 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F ABBVIE COM 00287Y109 21,211,382 -522,541 -2.40 4,613,263 -7.10 0.1251
2026-02-17 2025-12-31 13F ABBVIE COM 00287Y109 21,733,923 -312,304 -1.42 4,965,984 -2.72 0.1306
2025-11-14 2025-09-30 13F ABBVIE COM 00287Y109 22,046,227 32,853 0.15 5,104,583 24.92 0.6530
2025-08-13 2025-06-30 13F ABBVIE COM 00287Y109 22,013,374 -546 -0.00 4,086,122 -11.41 0.5619
2025-05-13 2025-03-31 13F ABBVIE COM 00287Y109 22,013,920 189,294 0.87 4,612,357 18.93 0.6848
2025-02-14 2024-12-31 13F ABBVIE COM 00287Y109 21,824,626 2,299,645 11.78 3,878,236 0.58 0.5491
2024-11-13 2024-09-30 13F ABBVIE COM 00287Y109 19,524,981 -759,111 -3.74 3,855,793 10.83 0.6312
2024-08-14 2024-06-30 13F ABBVIE COM 00287Y109 20,284,092 33,832 0.17 3,479,127 -5.65 0.5862
2024-05-14 2024-03-31 13F ABBVIE COM 00287Y109 20,250,260 -685,853 -3.28 3,687,572 13.66 0.6371
2024-02-13 2023-12-31 13F ABBVIE COM 00287Y109 20,936,113 -1,000,166 -4.56 3,244,469 -0.78 0.5873
2023-11-13 2023-09-30 13F ABBVIE COM 00287Y109 21,936,279 491,391 2.29 3,269,822 13.17 0.6333
2023-08-11 2023-06-30 13F ABBVIE COM 00287Y109 21,444,888 -780,116 -3.51 2,889,270 -18.43 0.5552
2023-05-15 2023-03-31 13F ABBVIE COM 00287Y109 22,225,004 268,579 1.22 3,541,999 -0.18 0.7022
2023-02-13 2022-12-31 13F ABBVIE COM 00287Y109 21,956,425 101,629 0.47 3,548,378 20.98 0.7446
2022-11-14 2022-09-30 13F ABBVIE COM 00287Y109 21,854,796 -319,948 -1.44 2,933,132 -13.64 0.6700
2022-08-12 2022-06-30 13F ABBVIE COM 00287Y109 22,174,744 -456,417 -2.02 3,396,283 -7.43 0.7274
2022-05-13 2022-03-31 13F ABBVIE COM 00287Y109 22,631,161 -186,365 -0.82 3,668,737 18.75 0.6454
2022-02-08 2021-12-31 13F ABBVIE COM 00287Y109 22,817,526 1,806 0.01 3,089,492 25.53 0.5061
2021-11-15 2021-09-30 13F ABBVIE COM 00287Y109 22,815,720 161,083 0.71 2,461,131 -3.55 0.4356
2021-08-13 2021-06-30 13F ABBVIE COM 00287Y109 22,654,637 -1,072,864 -4.52 2,551,818 -0.62 0.4495
2021-05-12 2021-03-31 13F ABBVIE COM 00287Y109 23,727,501 -185,978 -0.78 2,567,792 0.21 0.4776
2021-02-11 2020-12-31 13F ABBVIE COM 00287Y109 23,913,479 -449,713 -1.85 2,562,330 20.07 0.4991
2020-11-16 2020-09-30 13F ABBVIE COM 00287Y109 24,363,192 210,056 0.87 2,133,971 -10.01 0.4679
2020-08-14 2020-06-30 13F ABBVIE COM 00287Y109 24,153,136 3,808,707 18.72 2,371,355 52.99 0.5618
2020-05-14 2020-03-31 13F ABBVIE COM 00287Y109 20,344,429 895,939 4.61 1,550,043 -9.98 0.4450
2020-02-14 2019-12-31 13F ABBVIE COM 00287Y109 19,448,490 -182,144 -0.93 1,721,969 15.85 0.3854
2019-11-13 2019-09-30 13F ABBVIE COM 00287Y109 19,630,634 -525,315 -2.61 1,486,430 1.41 0.3558
2019-08-13 2019-06-30 13F ABBVIE COM 00287Y109 20,155,949 -56,135 -0.28 1,465,740 -10.02 0.3477
2019-05-13 2019-03-31 13F ABBVIE COM 00287Y109 20,212,084 -817,581 -3.89 1,628,892 -15.98 0.4023
2019-02-12 2018-12-31 13F ABBVIE COM 00287Y109 21,029,665 227,408 1.09 1,938,725 -1.46 0.5438
2018-11-14 2018-09-30 13F ABBVIE COM 00287Y109 20,802,257 -425,114 -2.00 1,967,477 0.04 0.4815
2018-09-18 2018-06-30 13F/A-1 ABBVIE COM 00287Y109 21,227,371 -425,398 -1.96 1,966,717 -4.04 0.4994
2018-08-14 2018-06-30 13F ABBVIE COM 00287Y109 21,331,676 -321,093 1,976,381
2018-05-09 2018-03-31 13F ABBVIE COM 00287Y109 21,652,769 -449,836 -2.04 2,049,436 -4.12 0.5332
2018-02-14 2017-12-31 13F ABBVIE COM 00287Y109 22,102,605 -220,261 -0.99 2,137,542 7.76 0.5413
2017-11-13 2017-09-30 13F ABBVIE COM 00287Y109 22,322,866 1,219,921 5.78 1,983,611 29.63 0.5170
2017-08-11 2017-06-30 13F ABBVIE COM 00287Y109 21,102,945 -219,511 -1.03 1,530,175 10.13 0.4279
2017-05-12 2017-03-31 13F ABBVIE COM 00287Y109 21,322,456 -133,177 -0.62 1,389,371 3.41 0.4006
2017-02-13 2016-12-31 13F ABBVIE COM 00287Y109 21,455,633 -220,741 -1.02 1,343,551 -1.72 0.4121
2016-11-09 2016-09-30 13F ABBVIE COM 00287Y109 21,676,374 -303,888 -1.38 1,367,129 0.47 0.4258
2016-08-12 2016-06-30 13F ABBVIE COM 00287Y109 21,980,262 -47,319 -0.21 1,360,798 8.27 0.4418
2016-08-19 2016-03-31 13F/A-1 ABBVIE COM 00287Y109 22,027,581 -292,030 -1.31 1,256,812 -4.95 0.4169
2016-05-13 2016-03-31 13F Abbvie COMM 00287Y109 22,027,492 1,258,212
2016-02-12 2015-12-31 13F Abbvie COMM 00287Y109 22,319,611 -1,497,409 -6.29 1,322,213 2.03 0.4383
2015-11-12 2015-09-30 13F Abbvie COMM 00287Y109 23,817,020 -1,257,523 -5.02 1,295,883 -23.08 0.4325
2015-08-13 2015-06-30 13F ABBVIE COM 00287Y109 25,074,543 826,611 3.41 1,684,759 18.69 1.1421
2015-08-13 2015-06-30 13F Abbvie COMM 000287Y10 508,512 -23,739,420 34,167 0.0232
2015-05-14 2015-03-31 13F Abbvie COMM 00287Y109 24,247,932 -106,888 -0.44 1,419,473 -10.94 0.4269
2015-02-12 2014-12-31 13F Abbvie COM 00287Y109 24,354,820 -112,783 -0.46 1,593,780 12.77 0.4812
2014-11-13 2014-09-30 13F Abbvie COMM 00287Y109 24,467,603 -977,586 -3.84 1,413,248 -1.59 0.4438
2014-08-14 2014-06-30 13F ABBVIE com 00287Y109 25,445,189 -152,622 -0.60 1,436,126 9.15 0.4476
2014-05-14 2014-03-31 13F ABBVIE COM 00287Y109 25,597,811 -256,430 -0.99 1,315,727 -3.64 0.4139
2014-02-21 2013-12-31 13F/A-1 ABBVIE COM 00287Y109 25,854,241 510,071 2.01 1,365,362 20.44 0.4379
2014-02-12 2013-12-31 13F ABBVIE COM 00287Y109 25,854,241 1,365,362
2013-11-13 2013-09-30 13F ABBVIE COM 00287Y109 25,344,170 -961,821 -3.66 1,133,644 4.24 0.3993
2013-08-09 2013-06-30 13F ABBVIE COM 00287Y109 26,305,991 26,305,991 1,087,489 0.3941
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.